Hindustan Agrigenetics (BSE 519574)₹36.38+3.94%Other Agricultural Products
In the Mar 2026 quarter (standalone), Hindustan Agrigenetics reported sales of ₹0 Cr and net profit of −₹0.42 Cr. For the year to Mar 2026, sales were ₹0.05 Cr and net profit ₹0.14 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.05 | 0.00 | 0.04 | 0.00 | 0.05 | 0.00 | 0.04 | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.04 | 0.06 | −0.05 | 0.02 | 0.00 | 0.00 | 0.23 | 0.70 | 0.13 | 0.04 | 0.23 | 0.82 |
| Operating Profit | 0.02 | −0.08 | 0.10 | 0.00 | 0.04 | 0.00 | −0.20 | −0.70 | −0.11 | −0.06 | −0.23 | −0.84 |
| OPM % | 25.0% | — | 300.0% | — | 75.0% | — | −700.0% | — | −250.0% | — | — | — |
| Other Income | 0.15 | 0.17 | 0.16 | 0.16 | 0.03 | 0.16 | 0.25 | 0.19 | 0.52 | 0.26 | 0.21 | 0.58 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Profit before tax | 0.16 | 0.09 | 0.24 | 0.14 | 0.05 | 0.15 | 0.03 | −0.53 | 0.41 | 0.20 | −0.06 | −0.29 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 50.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 |
| Net Profit | 0.16 | 0.08 | 0.23 | 0.14 | 0.05 | 0.15 | 0.03 | −0.53 | 0.41 | 0.20 | −0.05 | −0.42 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.07 | 0.07 | 0.06 | 0.07 | 0.20 | 0.07 | 0.07 | 0.08 | 0.08 | 0.09 | 0.05 | 0.05 |
| Expenses | 0.11 | 0.15 | 0.22 | 0.23 | 0.60 | 0.20 | 0.24 | 0.72 | 0.38 | 1.11 | 0.86 | 1.22 |
| Operating Profit | −0.07 | −0.11 | −0.15 | −0.17 | −0.41 | −0.14 | −0.18 | −0.65 | −0.29 | −1.03 | −0.84 | −1.24 |
| OPM % | −100.1% | −166.7% | −320.0% | −266.7% | −210.6% | −216.7% | −283.4% | −914.3% | −428.6% | −1,275.0% | −2,075.0% | −2,480.0% |
| Other Income | 0.96 | 0.29 | 0.20 | 0.05 | 0.05 | −0.06 | 0.07 | 10.57 | 0.97 | 0.77 | 1.15 | 1.57 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.05 | 0.05 | 0.04 | 0.08 |
| Profit before tax | 0.89 | 0.18 | 0.03 | −0.14 | −0.38 | −0.19 | −0.12 | 9.95 | 0.61 | −0.32 | 0.28 | 0.26 |
| Tax % | 25.0% | 35.3% | 3,100.0% | −7.7% | −186.5% | −16.7% | −9.1% | 0.5% | 23.3% | 0.0% | 51.8% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 |
| Net Profit | 0.67 | 0.12 | −0.60 | −0.13 | 0.34 | −0.16 | −0.11 | 9.88 | 0.48 | −0.32 | 0.14 | 0.14 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.40 | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 | 4.41 | 4.41 | 4.41 | 4.41 | 4.41 |
| Reserves | −2.35 | −1.69 | −1.63 | −2.22 | −2.48 | −2.16 | −2.30 | −2.39 | 7.44 | 7.91 | 7.59 | 7.73 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 1.00 | 0.23 | 0.15 | 0.16 | 0.22 | 0.28 | 0.85 | 6.16 | 0.51 | 0.43 | 0.39 | 0.25 |
| Total Liabilities | 3.05 | 2.93 | 2.91 | 2.33 | 2.13 | 2.51 | 2.94 | 8.18 | 12.36 | 12.75 | 12.39 | 12.39 |
| Fixed Assets | 0.35 | 0.34 | 0.33 | 0.34 | 0.35 | 0.35 | 0.34 | 0.34 | 0.04 | 0.18 | 0.15 | 0.12 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.44 | 1.56 | 1.57 | 1.58 | 1.37 | 0.20 | 1.34 | 1.74 | 0.84 | 1.96 | 3.63 | 3.29 |
| Other Assets | 1.26 | 1.03 | 1.01 | 0.41 | 0.41 | 1.96 | 1.26 | 6.10 | 11.48 | 10.61 | 8.61 | 8.98 |
| Cash & equivalents | 0.06 | 0.06 | 0.06 | 0.08 | 0.05 | 0.30 | 0.18 | 5.02 | 10.28 | 9.52 | 5.16 | 5.64 |
| Total Assets | 3.05 | 2.93 | 2.91 | 2.33 | 2.13 | 2.51 | 2.94 | 8.18 | 12.36 | 12.75 | 12.39 | 12.39 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −0.05 | −0.05 | −0.21 | −0.11 | −0.25 | −0.66 | 1.08 | 5.18 | −6.53 | 0.20 | 0.08 | 0.53 |
| Cash from investing activity | 0.07 | 0.06 | 0.22 | 0.13 | 0.23 | 0.90 | −1.20 | −0.34 | 11.78 | −0.94 | −4.42 | 0.15 |
| Cash from financing activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.01 | 0.00 | −0.17 |
| Net cash flow | 0.03 | 0.02 | −0.02 | 0.03 | −0.03 | 0.26 | −0.14 | 4.85 | 5.24 | −0.77 | −4.35 | 0.49 |
| Capex | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 | 0.00 | 0.00 |
| Free cash flow | −0.06 | −0.03 | −0.21 | −0.11 | −0.28 | −0.64 | 1.08 | 5.18 | 3.94 | 0.02 | 0.08 | 0.67 |
| CFO / OP % | 20.0% | 66.9% | 179.9% | 61.9% | 149.9% | 162.0% | −823.1% | −3,041.1% | 1,019.0% | −63.0% | −7.0% | −80.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory days | 0 | 0 | 0 | 0 | 0 | 0 | — | — | 0 | 0 | 0 | 0 |
| Cash conversion cycle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working capital days | −5,353 | −730 | −243 | −365 | −608 | 884 | −4,502 | −36,926 | −1,669 | 730 | 11,543 | 51,830 |
| ROCE % | −2.0% | 33.6% | 0.0% | 0.8% | −1.9% | −13.4% | −6.0% | −7.8% | 144.9% | 2.1% | −3.5% | 1.3% |
For the Mar 2026 quarter, Hindustan Agrigenetics reported sales of ₹0 Cr and net profit of −₹0.42 Cr.
Hindustan Agrigenetics' sales for the year to Mar 2026 were ₹0.05 Cr; over the last twelve months they were ₹0.05 Cr.
Net profit for the year to Mar 2026 was ₹0.14 Cr, and ₹0.14 Cr over the last twelve months.
Hindustan Agrigenetics reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹5.64 Cr.
Cash from operations was ₹0.53 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.67 Cr.